Acumen Pharmaceuticals Inc (ABOS)
2.40
+0.04
(+1.69%)
USD |
NASDAQ |
Jun 28, 16:00
2.40
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Free Cash Flow: -50.78M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -50.78M |
| December 31, 2023 | -43.08M |
| September 30, 2023 | -46.00M |
| June 30, 2023 | -42.35M |
| March 31, 2023 | -37.18M |
| December 31, 2022 | -35.31M |
| September 30, 2022 | -27.74M |
| Date | Value |
|---|---|
| June 30, 2022 | -26.17M |
| March 31, 2022 | -23.94M |
| December 31, 2021 | -17.96M |
| September 30, 2021 | -17.18M |
| June 30, 2021 | -10.77M |
| March 31, 2021 | -8.004M |
| December 31, 2020 | -7.45M |
Free Cash Flow Range, Past 5 Years
-50.78M
Minimum
Mar 2024
-7.45M
Maximum
Dec 2020
-28.14M
Average
-26.96M
Median
Free Cash Flow Benchmarks
| Accuray Inc | -24.08M |
| Kezar Life Sciences Inc | -83.65M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.86M |
| Cash from Investing (Quarterly) | -9.203M |
| Cash from Financing (Quarterly) | 7.107M |
| Free Cash Flow Per Share (Quarterly) | -0.2988 |
| Free Cash Flow Yield | -39.72% |